Literature DB >> 19141369

Haplotype analysis of beta thalassemia patients in Western Iran.

Zohreh Rahimi1, Adriana Muniz, Reza Akramipour, Fareidon Tofieghzadeh, Hadi Mozafari, Asad Vaisi-Raygani, Abbas Parsian.   

Abstract

Beta-thalassemia (beta-thal) is the most common single gene disorder in Iran. To determine the chromosomal background of beta thalassemia mutations in Western Iran we studied beta-globin gene cluster haplotypes in 314 beta-thal and 70 beta(A) chromosomes with a Kurd ethnic background from the province of Kermanshah, Iran using PCR-RFLP. beta-thal mutations were analyzed using PCR-ARMS, RFLP and direct genomic sequencing. Haplotypes were constructed by analyzing the pattern of seven restriction sites through the beta-globin gene cluster. Haplotype I was the most prevalent haplotype (35.7%) among beta-thal chromosomes followed by haplotype III (28.6%). beta(A) chromosomes similar to beta-thal chromosomes were linked to diverse haplotypes but predominantly with haplotype I (42.9%). The predominant IVSII-1 (G-->A) mutation in this population (33%) was strongly linked to haplotype III (66.1%) but was also found on chromosomes with haplotypes I, II, V, X and atypical. The second prevalent mutation was CD8/9 +G (13.5%) and showed a strong association with haplotype I (96.4%) and a weak association with haplotype V (3.6%). Haplotype background for Kurdish mutations among our studied population was similar to those among Kurdish Jews and people of Kurdistan of Iran. Identification of the most common mutations on different haplotype backgrounds can be explained by a variety of gene conversion and recombination events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19141369     DOI: 10.1016/j.bcmd.2008.12.001

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

1.  Abnormal hemoglobins among Kurdish population of Western Iran: hematological and molecular features.

Authors:  Zohreh Rahimi; Adriana Muniz; Hadi Mozafari
Journal:  Mol Biol Rep       Date:  2009-03-31       Impact factor: 2.316

2.  Alteration of T Cell Subtypes in Beta-Thalassaemia Major: Impact of Ferritin Level.

Authors:  Batoul Pourgheysari; Leila Karimi; Pezhman Beshkar
Journal:  J Clin Diagn Res       Date:  2016-02-01

3.  Low IL-2 Expressing T Cells in Thalassemia Major Patients: Is It Immune Aging.

Authors:  Batoul Pourgheysari; Leila Karimi; Raihaneh Bagheri; Soleiman Kheiri
Journal:  Indian J Hematol Blood Transfus       Date:  2018-03-07       Impact factor: 0.900

Review 4.  Genetic epidemiology, hematological and clinical features of hemoglobinopathies in Iran.

Authors:  Zohreh Rahimi
Journal:  Biomed Res Int       Date:  2013-06-18       Impact factor: 3.411

5.  Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran.

Authors:  Mohammad Bagher Hashemi-Soteh; Seyed Saeed Mousavi; Alireza Tafazoli
Journal:  J Biomed Sci       Date:  2017-12-04       Impact factor: 8.410

6.  A Cross-Sectional Study of Detection of Beta Globin (HBB) Haplotypes Among Beta Thalassemia Patients.

Authors:  Ali Alsamiri; Fatma Alzahrani; Najlaa Filimban; Ammar Khojah; Raed Felimban; Talal Qadah
Journal:  Cureus       Date:  2021-02-16

7.  Haplotype Analysis in Carriers of β-Globin Gene Mutation Facilitates Genetic Counseling in β-Thalassemia: A Cross-Sectional Study in Kerman Province, Iran.

Authors:  Nasrollah Saleh-Gohari; Kolsoum Saeidi; Sima Ziaadini-Dashtkhaki
Journal:  Iran J Public Health       Date:  2020-04       Impact factor: 1.429

8.  Cost-utility of new film-coated tablet formulation of deferasirox vs deferoxamine among major beta-thalassemia patients in Iran.

Authors:  Parisa Saiyarsarai; Elahe Khorasani; Hasti Photogeraphy; Mohsen Ghaffari Darab; Meysam Seyedifar
Journal:  Medicine (Baltimore)       Date:  2020-07-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.